Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Latest figures from the government have said a further 1,001 people have died within 28 days of testing positive for Covid-19 on Wednesday.
There have also been a further 13,013 more lab-confirmed cases of coronavirus in the UK as of 9am, bringing the total number of cases to 3,985,161.
The official coronavirus death toll in the UK now stands at 114,851.
Government data up to 9 February shows that of the 13,577,851 jabs given in the UK so far, 13,058,298 were first doses - a rise of 411,812 on the previous day.
This means nearly one in four adults in the UK have received a first dose.
Some 519,553 were second doses, an increase of 3,161 on figures released the previous day.
It comes as the World Health Organisation (WHO) recommended the use of the Oxford/AstraZeneca jab in all adults, after several countries opted not to give the jab to people aged over 65.
Dr Alejandro Cravioto, chairman of the WHO's Strategic Advisory Group of Experts on Immunisation, told a press briefing: "In the case of the data coming from clinical trials, we have seen that there was a small participation of people over 65 years of age.
"However, the results of the efficacy estimate for persons up to 65 and older, had a wide confidence interval. And therefore we feel that the response of this group cannot be any different to groups that are of a younger age.
"Since we have identified people over 65 was one of our priority groups in the prioritisation roadmap... looking at the safety and immunogenicity data... we recommend for the vaccine to be used in people 18 years and above, without an upper age limit.
"That means people over 65 years of age should be given the vaccination."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments